Objectives: The vascular depression hypothesis posits that cerebrovascular burden contributes to the development of depression symptoms in late life. Building on work that suggests that vascular depression is a prodrome for frailty, this paper tests a theoretical framework that vascular depression symptoms are an early marker of a broader pattern of decline characterized by more frailty symptoms and shortened lifespan, and that vascular depression symptoms predict mortality through frailty. Methods: The sample was drawn from the Health and Retirement Study and included 1361 stroke-free women over the age of 80. Data were included from six biannual waves from 1998 to 2008 (waves 4-9). A vascular depression symptomatology variable was based on Center for Epidemiological Studies Depression Scale (CES-D) scores and number of cerebrovascular risk factors (hypertension, diabetes, cardiac disease, and smoking). Frailty was measured based on wasting, slowness, weakness, fatigue, and falls. Vascular depression and frailty symptoms were modeled using slope and intercept terms. Mortality was modeled using a discrete-time survival term. Results: The data supported the proposed model (RMSEA ¼ 0.051; CFI ¼ 0.971; X 2 ¼ 234.84, p < 0.001). Higher vascular depression symptom slope and intercept scores significantly predicted higher frailty slope and intercept scores, respectively. Frailty intercept scores significantly predicted mortality. The vascular depression symptoms indirectly predicted mortality through frailty symptoms. A second model testing the competing hypothesis -that frailty symptoms lead to vascular depression symptoms and indirectly to mortality -was not supported by the data. Conclusions: Results suggest that vascular depression symptoms are associated with a clinical trajectory that includes greater frailty and shortened remaining lifespan.
Concurrent with the rapidly increasing numbers of older-old adults in the U.S., the syndrome of frailty is becoming increasingly common. Up to 30% of elders die with, or because of, frailty (Fassbender, Fainsinger, Carson, & Finegan, 2009; Paulson & Lichtenberg, 2011a) , and frail elders' need for extensive care makes this syndrome among the most costly causes of death (Fassbender et al., 2009) . Older women live longer than men, but are at higher risk for disability and depression, placing them at higher risk for frailty (Paulson & Lichtenberg, 2013) . Risks associated with depression and frailty become exaggerated in late life, making age 80 an important time to reassess patient prognosis and treatment goals. Our objectives were to evaluate a theoretical framework that describes an adverse clinical trajectory among older-old women. The proposed framework specifies a temporal relationship between symptoms of (1) vascular depression, (2) frailty, and (3) mortality. We tested this model in a sample of stroke-free women over the age of 80.
The proposed model is based on the well-established finding that high cerebrovascular burden (CVB), characterized here by hypertension, diabetes, cardiac disease, and smoking history, slowly erodes the capacity for adaptive functioning over many years (Flicker, 2010; Pugh & Lipsitz, 2002) . The term 'adaptive functioning' can be broadly interpreted, but this model emphasizes depression, frailty, and mortality risk -three primary areas of concern for both the aging patient population and the public healthcare system. Although both vascular depression and frailty symptoms (Cawthon et al., 2007; Fried et al., 2001 ) have been directly associated with heightened mortality rates, the proposed model posits that vascular depression symptoms are an early indicator of a broader pattern of decline that is subsequently characterized by higher rates of frailty symptoms and mortality.
High CVB undermines late-life adaptive functioning in numerous ways, and onset of depression symptoms is chief among those. The vascular depression hypothesis (Alexopoulos et al., 1997) posits that high CVB compromises neurological functioning, particularly in frontostriatal areas, and that as a result, depression symptoms develop. Vascular depression theory has produced two complementary lines of research. One describes how CVB-mediated neurological changes -and prefrontal white-matter hyperintensities in particular -predict higher rates of depression among elders (Coffey, Figiel, Djang, & Weiner, 1990; Sneed, Rindskopf, Steffens, Krishnan, & Roose, 2008) . The second line of vascular depression research describes clinically defined vascular depression, in which greater depression symptoms are predicted by comorbidities such as diabetes, hypertension, and cardiac disease (Mast, Neufeld, MacNeill, & Lichtenberg, 2004; Yochim, Mast, & Lichtenberg, 2003) . Consistent with these findings, another study from our lab (Paulson, Bowen, & Lichtenberg, in press) found that in the same sample used in the present study, older women with high CVB reported more depression symptoms and were at increased risk for probable depression. While results have been mixed for both neuroradiological (Rainer et al., 2006) and clinical studies (Lyness et al., 1999) , both approaches generally support vascular depression theory. Of particular relevance to this synthesis, elders with high CVB and depression have much higher mortality rates than their healthier counterparts (Lavretsky et al., 2010) .
In our proposed model, vascular depression symptoms are an early indicator of the decline of brain integrity, with frailty symptoms emerging later as neurological damage continues to accrue. In this way, vascular depression is conceptualized as one entry point into the cycle of frailty. Broadly speaking, frailty symptoms can be viewed as the combined effects of life stress that result in multisystemic dysregulation of homeostatic systems (Clegg, 2011; Fried, Ferrucci, Darer, Williamson, & Anderson, 2004) , leading to homeostenosis, or impaired homeostatic maintenance during periods of acute stress (Powell, 1997) . In this study, frailty was measured using the PaulsonLichtenberg frailty index (PLFI), a model based on Fried et al.'s (2001) work, and includes wasting, weakness, slowness, fatigue, and falls. Validated using Health and Retirement Study (HRS) data, this frailty index identifies higher rates of frailty among the older-old, women, minorities, and those with greater medical burden, probable depression, cognitive impairment, and activity of daily living (ADL) or instrumental activity of daily living (IADL) disability. As in Fried et al.'s (2001) research, respondents identified as frail using this index are more likely to experience hospitalization and are at higher mortality risk (Paulson & Lichtenberg, 2011a . Katz (2004) and Mast (2010) have noted that both late-life depression and frailty share numerous phenomenological and theoretical similarities, including rates of white matter hyperintensities. They have also noted that depression, particularly in the context of high CVB, may precede and predict frailty. This hypothesis was supported by Lakey et al.'s (2012) research on middle-aged and older adults. Our earlier study (Paulson & Lichtenberg, 2013 ) using the same sample as this study, concluded that over a four-year interval, elders with both high CVB and probable depression have a greater risk of both prevalent and incident frailty than those with either high CVB or probable depression alone. By contrast, a recent review by Mezuk, Edwards, Lohman, Choi, and Lapane (2012) argues that the relationship between depression and frailty is bidirectional. The review was complemented by an empirical study (Mezuk, Lohman, Dumenci, & Lapane, in press) suggesting that frailty and depression are independent constructs, but often overlap in patient populations. Our previous study did not test the competing hypothesisthat frailty predicts vascular depression symptomatologyas suggested by Mezuk et al.'s review examining late-life depression and frailty without regard to etiology. It may be, however, that vascular depression, a particular subtype of depression, has a temporal ordering with frailty. Moreover, these past studies have not described the indirect relationships from vascular depression symptomatology through frailty to mortality, as predicted by the proposed model, or conversely, from frailty through vascular depression symptomatology to mortality.
The proposed model describes a dynamic process that develops over a period of years. Accordingly, detection of these effects requires a longitudinal research design that uses large-scale cohort panel data, such as the HRS. The hypothesis tested in this paper posits that in a sample of stroke-free women over the age of 80, vascular depression symptoms will (1) predict frailty and (2) predict mortality indirectly through frailty. To test the specificity of our model, however, we will also examine whether frailty will (1) predict vascular depression symptoms and (2) predict mortality indirectly through vascular depression symptomatology.
Method Sample
The HRS is a National Institute on Aging -supported prospective, multistage cohort study of the U.S. households (Heeringa & Conner, 1995) . The HRS data include four smaller samples consisting of (1) respondents from the original (1992) HRS who were aged between 51 and 61 that year, (2) the Asset and Health Dynamics of the Oldest Old study, which included participants over age 70 and was merged with the HRS in 1998, and (3) two additional samples selected in 1998 to better represent the population of retired adults in the U.S. Most HRS survey data are collected at two-year intervals.
A subsample of HRS respondents consisting of women who were 80 years or older in 1998 formed the baseline for this study. Respondents were excluded if, in 1998, they reported a history of stroke or were unable to independently respond to survey materials (e.g., the Center for Epidemiological Studies Depression Scale [CES-D], a measure of depressive symptoms). We then incorporated data from the six biennial waves (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) .
Measures

Self-reported medical conditions
Medical data (hypertension, diabetes, and history of heart disease) and lifetime history of smoking were collected by self-report. Hypercholesterolemia was not included, because it was not reported in the data at every wave. Incidence of death was identified at each wave. In the case of deaths, the exact date within the two-year period was not known.
Depressive symptoms
Depression was measured using a shortened, eight-item form of the original CES-D (Radloff, 1977) . Six of the eight items are negatively worded and two are positively worded. Participants are asked to respond 'yes' or 'no' to each item ('was depressed,' 'everything was an effort,' 'sleep was restless,' 'was happy,' 'felt lonely,' 'enjoyed life,' 'felt sad,' and 'could not get going'), based on whether or not they had experienced it during the preceding week. Scores ranged from 0 to 8, with higher scores indicating greater depressive symptoms. Using HRS data, the reliability of the eight-item CES-D was adequate, with high Cronbach's alpha based on both normative data (0.81-0.83; Steffick, 2000) and the sample used in this study (a ¼ 0.72). This measure has been found to be a valid index of mood in late life (Steffick, 2000) and is broadly used in epidemiological studies of late-life depression (Beekman et al., 1997) . Recommended clinical cutoffs for this measure suggest interpreting CES-D scores ! 3 (Steffick, 2000) as indicative of probable clinical depression.
Vascular-depression symptoms
In this study, vascular depression symptomatology was measured as a dimensional variable. In keeping with past work (Paulson & Lichtenberg, 2011a) , depression symptomatology and CVB were integrated to form a single variable representing vascular depression symptomatology. As displayed in Figure 1 , respondents with 0 or 1 cerebrovascular risk factor (CVRF; hypertension, diabetes, cardiac disease, or smoking history) and a CES-D score of 0 or 1 were assigned a score of 1 (description: very healthy). Those with 1 CVRF and CES-D scores of 1 or 2 were assigned a score of 2 (description: healthy), as were those with 0 CVRFs and a CES-D score of 2. Respondents with 2 or more CVRFs or a CES-D score ! 3 were assigned a score of 3 (description: high CVB or probable depression). Respondents with 2 or more CVRFs and CES-D scores of 3 or 4 were assigned a score of 4 (description: mild vascular depression symptoms). Those with more than 2 CVRFs and CES-D scores ! 5 were assigned a score of 5 on the vascular depression symptomatology variable (description: moderate-to-severe vascular depression symptoms). Vascular depression symptomatology was measured in all six waves from 1998 to 2008.
Self-rated health
Self-rated health was measured by comparing self-rated health reports (1 ¼ excellent, 2 ¼ very good, 3 ¼ good, 4 ¼ fair, and 5 ¼ poor) at adjacent time periods. Positive values indicate health deterioration over a two-year period. Negative values suggest improved health. Only the baseline (1998) self-rated health information was used.
Functional independence
ADLs were measured using five criteria: bathing, eating, dressing, walking across a room, and getting in or out of bed. IADLs were measured using three criteria: using a telephone, taking medication, and handling money. Scores were summed on both indices to indicate the number of items the respondent reported experiencing difficulty completing independently. Higher scores indicate greater disability. Only the baseline (1998) functional independence information was used.
Frailty
In this study, frailty was measured as a dimensional variable. We measured frailty symptomatology using the PLFI (Paulson & Lichtenberg, 2011a , a measure based on Fried et al.'s (2001) conceptualization. Due to differences between the HRS data and Fried's model of frailty, the PLFI includes the following five symptoms: wasting, weakness, slowness, fatigue or exhaustion, and falls. The wasting criterion was met if a respondent reported loss of at least 10% of body weight over a twoyear period. The weakness criterion was met if she endorsed the question, 'Because of health problems, do you have any difficulty with lifting or carrying weights over 10 pounds, like a heavy bag of groceries?' The slowness criterion was met if respondents answered in the affirmative to the question, 'Because of a health problem, do you have any difficulty with getting up from a chair after sitting for long periods?' The fatigue or exhaustion criterion was met if the respondent answered in the affirmative to the question, 'Since we last talked with you in [the last wave], have you had any of the following persistent or troublesome problems: . . . severe fatigue or exhaustion?' The falls criterion was met if the respondent answered in the affirmative to the question, 'Have you fallen down in the past 2 years?' While Fried's criteria include low energy expenditure, this variable was not available in the HRS data. Instead, the frailty-symptom list was modified to include falls, which have been found to be an indirect measure of energy expenditure (MonteroOdasso et al., 2011) . None of the frailty items was drawn from the CES-D or from the functional independence scales described above. This frailty index was used as a semicontinuous (discrete count) variable. Complete frailty data were available at the 2000, 2004, and 2008 waves.
Statistical methodology
Integrated disease models attempt to describe complex interrelationships between disease processes, ultimately representing a complex clinical trajectory. Raykov (2007) described a strategy for examining parallel processes, such as developmental processes or disease states, involves the specification of latent variables representing mean values at baseline (intercept) and rate of change over time (slope). This strategy can accommodate missing data, thus preventing bias that results from excluding more vulnerable participants for whom missing data exists (Rabbitt, Lunn, & Wong, 2008) . The model employed in this study permits examination of how individuals' baseline scores for a particular variable predict change over time for that same variable. In addition, this model facilitates examination of how baseline scores and rate of change over time for one variable or process predict baseline scores and rate of change over time for a separate variables or process. Finally, this strategy permits calculation of indirect effects. The examination of these multiple relationships using traditional hypothesis-testing strategies would require numerous analyses, resulting in inflation of type-1 error rates. By comparison to traditional hypothesis-testing paradigms, the longitudinal modeling strategy employed in this study is a more parsimonious and robust method of describing longitudinal relationships between parallel, related disease process such as vascular depression and frailty.
Our primary objective was to test the described theoretical model, specifically addressing the hypothesis that vascular depression symptoms are an early indicator of a broader pattern of decline and predict mortality indirectly through frailty. We tested a model of temporal change that uses the intercept-and-slope model (Raudenbush & Bryk, 2002; Raykov & Marcoulides, 2008) . For clarity, Table 1 presents the series of relationships represented in this model. First, vascular depression symptoms were modeled using latent variables representing vascular depression symptom score at baseline (vascular depression symptom intercept), and rate of change in the vascular depression symptom score over time (vascular depression symptom slope). Similarly, frailty symptoms were modeled using latent variables representing frailty score at baseline (frailty intercept) and rate of change in frailty score over time (frailty slope). Mortality risk was modeled using a discrete time-survival term (Singer & Willett, 1993 ) based on mortality data at each wave. Thus, five latent variables were used to represent the primary variables of interest -vascular depression symptoms, frailty, and mortality. As such, this can be described as a fixed-effects model.
Frailty intercept and slope latent variables were regressed on vascular depression symptom intercept and slope latent variables. Mortality was then regressed on vascular depression slope and intercept latent variables, and on frailty slope and intercept latent variables. Then, the five latent variables representing the primary variables of interest were all regressed on the control variablesself-rated health change, ADLs, IADLs, and age. In this way, the influence of self-rated health, ADLs, IADLs and age were controlled in the model.
Longitudinal research with older adults is complicated by high attrition rates, in this case reflecting the high rates of mortality and disability. The conventional strategy of excluding respondents with incomplete data systematically underestimates disease severity and incorrectly estimates relationships with outcome variables. The full information maximum likelihood strategy (FIML; Arbuckle, 1996) was used to estimate parameters using all available information. Specifically, auxiliary variables identified as highly predictive of missing data (self-rated health change, ADLs, IADLs, and age) were used in both models to improve accuracy of parameter estimation (Graham, 2003) . In this way, data from all 1361 respondents with baseline data in the available sample were used, regardless of the availability of complete data on vascular depression symptoms and frailty symptoms. Less than 1% of the sample was missing data on any auxiliary variable. Data were prepared in SPSS V19 and analyses conducted using Mplus (Muthen & Muthen, 2007) . To evaluate the competing hypothesis -that frailty symptoms predict development of vascular depression symptoms and (indirectly) mortality through vascular depression symptomatology -a second structural model was tested wherein the directional pathways from vascular depression symptom to frailty latent variables were reversed. Finally, to ensure that our results were not artifacts produced by the use of FIML or incorporation of auxiliary variables, a mediation model, conceptually analogous to the structural model described above, was used to test the hypothesis that frailty mediates the relationship between vascular depression symptoms and mortality. This model used only CES-D at baseline, frailty at the 2000 wave, and incident mortality between 2002 and 2008. Data used for this mediation model included no missing values.
Results
The final sample included 1361 respondents with a mean age of 84.12 years (SD ¼ 4.10) and 10.85 years of education (SD ¼ 3.52; Table 2 Table 4 . In this model, high vascular depression symptom scores at intercept predicted both a flatter slope in vascular depression symptom scores over the course of the study and higher frailty symptom intercept scores. Higher vascular depression symptom scores at baseline were significantly predicted by greater ADL disability (b ¼ 0.47, p < 0.001) and greater IADL disability (b ¼ 0.30, p < 0.005). The rate of change in vascular depression symptoms (vascular depression symptom slope latent variable) was not predicted by any of the control variables. Higher scores on the frailty symptom intercept term were significantly predicted by greater age (b ¼ 0.23, p < 0.001) and greater ADL disability (b ¼ 0.32, p < 0.001). The frailty symptom slope variable was also not predicted by any control variables, though there was a marginally significant effect for older respondents to experience greater increase in frailty scores over the course of the study (b ¼ 0.10, p ¼ 0.06). Higher scores on the mortality term, indicating greater mortality risk, were significantly predicted by greater age (b ¼ 0.21, p < 0.001), more ADL disability (b ¼ 0.10, p < 0.001), and greater IADL disability (b ¼ 0.20, p < 0.001).
As shown in Figure 2 , higher vascular depression symptom scores at intercept predicted significantly slower rate of change in vascular depression symptom (b ¼ À0.35, p ¼ 0.03), indicating that respondents with few vascular depression symptoms at baseline had a greater increase in these symptoms over the course of the study. Higher vascular depression symptom scores at intercept predicted higher frailty scores at intercept (b ¼ 0.26, p < 0.001) indicating that respondents with more vascular depression symptoms at baseline (1998) had more frailty symptoms at the subsequent wave (2000) . There was also a strong trend for respondents with higher vascular depression symptom slope scores to have more frailty symptoms at baseline (b ¼ 0.14, p ¼ 0.06). Similarly, higher vascular depression symptom slope predicted higher frailty symptom slope (b ¼ 0.10, p ¼ 0.02) indicating that respondents with worsening vascular depression symptoms also had increasing frailty symptoms over the course of the study. Respondents with higher baseline frailty scores had attenuated frailty symptom slopes over the course of the study (b ¼ À0.33, p < 0.001) indicating that those who were less frail at baseline became more so over the course of the study. The frailty symptom intercept score significantly predicted mortality (b ¼ 0.02, p ¼ 0.04) indicating that respondents with more frailty symptoms at baseline had higher mortality rates. The relationship between the vascular depression symptom score at baseline and mortality showed a trend toward significance (b ¼ 0.01, p ¼ 0.09). The indirect relationship between the vascular depression symptom intercept term and mortality through the frailty intercept term was statistically significant (b ¼ 0.01, p ¼ 0.04).
To test the directly competing hypothesis -that frailty symptoms lead to vascular depression symptoms and, indirectly, to mortality through vascular depression symptoms -a post hoc model was completed in which the pathways from the vascular depression symptom intercept and slope variables to frailty intercept and slope variables were reversed. This post hoc model produced similar fit indices as the hypothesized model (RMSEA ¼ 0.05; CFI ¼ 0.97; X 2 ¼ 234.83, p < 0.001). In this modified model, greater vascular depression symptom scores at baseline were significantly predicted by higher baseline frailty symptom scores (b ¼ 0.69, p < 0.001) indicating that frailty predicts vascular depression symptoms crosssectionally at baseline. Change in vascular depression symptoms over the course of the study was predicted by vascular depression symptom intercept (b ¼ À0.45, p ¼ 0.007). Change in vascular depression symptoms, however, was not predicted by baseline frailty symptoms (b ¼ 0.52, p ¼ 0.28) or by change in frailty symptoms over time (b ¼ 0.58, p ¼ 0.73) . As in the primary model above, the only primary variables with significant direct effects on mortality were the frailty intercept (b ¼ 0.02, p ¼ 0.04), age (b ¼ 0.21, p < 0.001), ADL disability (b ¼ 0.10, p < 0.001), and IADL disability (b ¼ 0.20, p < 0.001). In sum, the results of these equations support a temporal relationship between baseline vascular depression symptomatology and later frailty, but do not support a temporal relationship between baseline frailty and later vascular depression symptomatology. In addition, the indirect pathway -from frailty through vascular depression symptomatology to mortality -is not statistically sig-
Finally, a mediation analysis was also completed (results not shown) testing the hypothesis that frailty symptomatology at wave 5 mediates the relationship between vascular depression symptoms at wave 4 and time to death. This analysis included 1113 participants for whom complete data on these three variables were available and included no imputed data points. Results of this analysis showed partial mediation using the Sobel test (p < 0.001) and were consistent with the primary findings of this study, suggesting that these conclusions are not an artifact of the modeling strategy.
Conclusions
Our primary finding is the elucidation of a temporal ordering and pathway from vascular depression symptoms to frailty symptoms to death. In our sample of stroke-free women over the age of 80, vascular depression symptoms predicted mortality through frailty symptoms. When the ordering of the model was reversed, however, frailty symptoms did not predict longitudinal change in vascular depression symptoms. These results support the proposed theoretical framework by describing a late-life clinical trajectory characterized by high vascular depression and frailty symptoms. It is important to note past work with this same sample concluded that neither high CVB alone nor high depression symptoms alone were as good at predicting frailty and/or mortality (Paulson & Lichtenberg, 2013) . Support was found for the hypothesis that vascular depression symptoms are prodromal of frailty symptoms toward the end of life in older-old women. We also found higher rates of vascular depression symptoms among elders with higher levels of ADL and IADL disability. In our sample of women over age 80, frailty symptoms were more common with high ADL disability. Mortality risk was significantly predicted by age and more ADL and IADL disability. Controlling for age, ADL and IADL disability, and self-reported health change, we found a progression from vascular depression symptoms to frailty symptoms to earlier mortality.
In this analysis, respondents who were frailer at baseline were more likely to die over the following waves, while healthier respondents became increasingly frail with the passage of time. This study did not find that elders with increasing frailty slope scores had higher mortality rates, as might be expected from both the theoretical model and other work on frailty (Fried et al., 2001 ). The respondents with higher frailty slope scores tended to be in better health at baseline, as indicated by lower frailty intercept scores. Consequently, change in frailty over time was not predictive of mortality in this analysis. These findings are not surprising, however, in light of the advanced age of our sample and the relatively poor health at baseline and high rate of mortality across the study period.
These results support the vascular depression hypothesis (Alexopoulos et al., 1997) , and clinically defined vascular depression in particular, and extend it by describing the emergence of vascular depression symptoms as an early stage in this chain of health decline. These findings also support work that relates frailty symptoms to mortality (Fried et al., 2001) . The finding that frailty leads to mortality demonstrates the central importance of this syndrome among the oldest old. In this sample, frailty predicts mortality at rates roughly similar to those found in other samples. Structural equation modeling, used in this study, is a rigorous statistical methodology with implications of causality, making this study one of the most stringent statistical tests of the frailty-mortality link in the literature.
These results also extend the frailty literature and contribute to the ongoing discussion of how we should define frailty. Emerging frailty research describes connections with various biomedical and disability-related covariates, including depression and CVB, often presenting a 'chicken and egg' problem regarding the emergence of these symptoms throughout late life. Deficit accumulation models of frailty (Rockwood et al., 1999) address this problem by overlapping with or subsuming mental health or functional independence variables. By contrast, phenotypic frailty models such as that proposed by Fried et al. (2001) , and the conceptualization used in this paper, delineate a construct that is related to, but independent of, mental health and functional independence. Incorporating a clearly defined frailty syndrome promotes a better understanding of both this common 'mechanism' of old age (Metchnikoff, 1903) and interventions that prevent (primary or secondary) or treat frailty. Specifically, past studies based on this same research found that CVB and depression independently predict mortality (Paulson, Bowen, & Lichtenberg, 2011b) , CVB is one cause of latelife depressive symptomatology (Paulson et al., in press) , and that the combination of high CVB and depressive symptomatology is a common pathway to frailty (Paulson & Lichtenberg, 2013) . In combination with the current findings that vascular depression symptomatology predicts mortality indirectly through frailty, this series of papers integrates phenotypic frailty into broader theoretical framework describing a late-life clinical trajectory.
Of particular significance, identification of clinical trajectories, such as the one described by this study, informs clinical conceptualizations of geriatric syndromes and guide intervention efforts. Our results suggest that interventions to reduce vascular burden throughout the lifespan may reduce depression and frailty in late life, thereby preserving capacity for self-care and quality of life. A second course of investigation suggested by these results relates to slowing the transition to frailty and prolonging independence. Arean and colleagues' (2010) work suggests that among older adults with depression, skillsbased interventions can improve capacity for self-care and reduce depression symptoms. However, whether skills-based interventions might slow the transition to frailty has not been explicitly studied.
One limitation of this study is that, while the relationship between vascular depression symptoms and mortality was small in magnitude, it may be underrepresented in this study. The most significant factor is that many respondents with high CVB were excluded from the study at baseline for having reported a stroke. Moreover, the HRS data includes community-dwelling older adults, so the most vulnerable elders may not be represented in this sample. Another significant factor is that this study includes mortality occurring between 2000 and 2008. The death of respondents who died after that time, who may have also had symptoms of vascular depression and frailty, was not reflected in this study. Nonetheless, the indirect relationship between vascular depression and mortality was significant, and deserves further study, perhaps with younger samples and over longer periods of time.
Other limitations of this study include the use of selfreported medical and depression symptom data. Future research using the HRS data could make use of biomarkers newly available in recent data releases. This might, for instance, involve blood pressure or glucose response as continuous variables that predict development of depression symptoms and frailty. At this time, the HRS data do not include diagnostic measurement of depression. Future research may build on these findings by incorporating clinical depression diagnosis, rather than depressive symptomatology as a continuous variable, as was done in this study. Additional limitations include absence of previous mental health history or information regarding current antidepressant treatment. This study also does not model the influence of current medical care, adherence to that care, or health behaviors such as diet and exercise. In addition, this study does not include current cognitive functioning as a predictor or marker of decline.
